Online citations, reference lists, and bibliographies.
← Back to Search

The Expected Burden Of Mesothelioma Mortality In Great Britain From 2002 To 2050

J. Hodgson, D. McElvenny, A. Darnton, M. Price, J. Peto
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The British mesothelioma register contains all deaths from 1968 to 2001 where mesothelioma was mentioned on the death certificate. These data were used to predict the future burden of mesothelioma mortality in Great Britain. Poisson regression analysis was used to model male mesothelioma deaths from 1968 to 2001 as a function of the rise and fall of asbestos exposure during the 20th century, and hence to predict numbers of male deaths in the years 2002–2050. The annual number of mesothelioma deaths in Great Britain has risen increasingly rapidly from 153 deaths in 1968 to 1848 in 2001 and, using our preferred model, is predicted to peak at around 1950 to 2450 deaths per year between 2011 and 2015. Following this peak, the number of deaths is expected to decline rapidly. The eventual death rate will depend on the background level and any residual asbestos exposure. Between 1968 and 2050, there will have been approximately 90 000 deaths from mesothelioma in Great Britain, 65 000 of which will occur after 2001.
This paper references
10.1136/oem.60.1.50
Update of predictions of mortality from pleural mesothelioma in the Netherlands
O. Segura (2003)
mesothelioma epidemic
J Peto (1995)
10.1093/AJE/KWH025
Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.
B. Price (2004)
10.1136/oem.31.2.91
Mesothelioma Register 1967-68
M. Greenberg (1974)
10.1093/OCCMED/KQI034
Mesothelioma mortality in Great Britain from 1968 to 2001.
D. McElvenny (2005)
10.5271/SJWEH.520
Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men.
J. Kjaergaard (2000)
Malignant mesothelioma in Australia
A. Musk (2006)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
Mesothelioma mortality in Great Britain from 1968 – 2001. (In press) Peto J (1979) Dose – response relationships for asbestos-related disease: implications for hygiene standards
Dm Mcelvenny (2005)
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1179/oeh.2003.9.3.206
Malignant Mesothelioma in Australia, 1945–2002
J. Leigh (2003)
10.1038/bjc.1982.15
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment.
J. Peto (1982)
mesothelioma mortality in Britain
J Peto (1982)
10.1111/j.1749-6632.1979.tb18720.x
DOSE‐RESPONSE RELATIONSHIPS FOR ASBESTOS‐RELATED DISEASE: IMPLICATIONS FOR HYGIENE STANDARDS PART II. MORTALITY
J. Petó (1979)
10.1136/oem.48.12.793
Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers.
G. Berry (1991)
Asbestos: effects on health of exposure to asbestos
R. Doll (1985)
10.1136/oem.55.11.760
Estimation of the past and future burden of mortality from mesothelioma in France.
A. G. Ilg (1998)
Latency periods in asbestos-related mesothelioma of the pleura.
C. Bianchi (1997)
10.1136/oem.56.2.110
Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos.
B. Järvholm (1999)
Discussion: Dose-Response Relationships for Asbestos-Related Disease; Implications for Hygiene Standards DOSE-RESPONSE RELATIONSHIPS FOR ASBESTOS-RELATED DISEASE: IMPLICATIONS FOR HYGIENE STANDARDS
H. C. Lewinsohn (2006)
10.1093/ANNHYG/41.INHALED_PARTICLES_VIII.129
Mesothelioma mortality in Britain: Patterns by birth cohort and occupation
J. Hodgson (1997)
Update of predictions of mortality
O Segura (2003)
Incidence rates of malignant mesothe
J Kjaergaard (2000)
Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge
(1991)



This paper is referenced by
10.1093/annonc/mdr324
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma.
N. Erčulj (2012)
10.18632/oncotarget.12408
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
I. Bononi (2016)
10.2217/THY.09.30
Pemetrexed in the treatment of malignant pleural mesothelioma
M. Peake (2009)
10.1016/j.aogh.2014.10.002
Occupational and environmental exposures and cancers in developing countries.
D. Hashim (2014)
10.1136/oemed-2015-103309
Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982–2009
M. Soeberg (2016)
10.1007/s10269-016-2642-4
Le mésothéliome : maladie orpheline ?
L. Greillier (2016)
10.1136/thx.2006.066886
The epidemiology and treatment of mesothelioma in South East England 1985–2002
V. Mak (2007)
10.1136/bcr-2013-009350
Simultaneous bilateral spontaneous hydropneumothorax: a rare presentation of bilateral malignant pleural mesothelioma
Hossam E Fayed (2013)
10.1016/j.ejca.2009.02.022
Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines.
J. Nutt (2009)
10.5380/CE.V21I2.46833
IMPACTO DA EXPOSIÇÃO AO AMIANTO NA SAÚDE DA POPULAÇÃO ADULTA: REVISÃO INTEGRATIVA
Fátima Denise Padilha Baran (2016)
10.1007/978-3-030-16884-1_1
Epidemiology of Mesothelioma
D. Mirabelli (2019)
10.3892/ijo.2016.3367
Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model.
Amr S Abu Lila (2016)
10.1016/j.lungcan.2009.05.016
Impact of malignant mesothelioma in Taiwan: a 27-year review of population-based cancer registry data.
L. Lee (2010)
10.1093/ANNONC/MDM093
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2007)
10.1002/9780470025079.CHAP49.PUB2
Pleura and Peritoneum
M. Sheaff (2007)
10.1093/OCCMED/KQM079
Simian virus 40 and mesothelioma in Great Britain.
M. Price (2007)
Malignant pleural mesothelioma : novel biomarkers and related pathways
Filip Mundt (2013)
10.1093/OCCMED/KQI034
Mesothelioma mortality in Great Britain from 1968 to 2001.
D. McElvenny (2005)
10.1016/j.chemosphere.2019.125691
Organochlorine pesticides induce inflammation, ROS production, and DNA damage in human epithelial ovary cells: An in vitro study.
H. Shah (2019)
10.1016/j.jfma.2018.07.013
Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Ro-Ting Lin (2019)
10.1038/sj.bjc.6605781
Projection of mesothelioma mortality in Britain using Bayesian methods
E. Tan (2010)
10.1515/CCLM.2010.165
Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population
Eun-Kee Park (2010)
10.1016/j.ejcts.2010.05.007
Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
S. Watzka (2011)
10.1136/thx.2007.087619
BTS statement on malignant mesothelioma in the UK, 2007
(2007)
10.1016/j.lungcan.2008.08.016
Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
L. Li (2009)
10.1016/J.LUNGCAN.2007.02.005
Malignant pleural mesothelioma: two cases in first degree relatives.
A. Wilkins (2007)
10.1259/bjr/30569427
Coarse pleural calcification in a mesothelioma patient raises the possibility of a rare tumour subtype: osteoblastic sarcomatoid mesothelioma.
A. Mortimer (2011)
10.3390/ijerph17020607
Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use
E. Oddone (2020)
Anmeldelse af udvalgte arbejdsbetingede kræfttilfælde (1994-2002) til Arbejdsskadestyrelsen
J. Hansen (2007)
10.1016/J.LUNGCAN.2006.08.012
EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
J. Edwards (2006)
10.2802/69206
New risks and trends in the safety and health of women at work: European risk observatory, a summary of an agency report
E. Flaspöler (2011)
10.5152/PB.2011.06
LOKAL ANESTEZI ILE YAPILAN TORAKOSKOPI: BRITANYA TORAKS DERNEGI PLEVRAL HASTALIKLAR REHBERI 2010
N. Rahman (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar